Gerrit Los

Gerrit Los

UNVERIFIED PROFILE

Are you Gerrit Los?   Register this Author

Register author
Gerrit Los

Gerrit Los

Publications by authors named "Gerrit Los"

Are you Gerrit Los?   Register this Author

26Publications

594Reads

42Profile Views

RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer.

Expert Opin Ther Targets 2020 Jan 27;24(1):1-5. Epub 2019 Dec 27.

Phoenix Molecular Designs, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728222.2020.1709824DOI Listing
January 2020

Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding.

BMC Genomics 2012 Jul 31;13:355. Epub 2012 Jul 31.

Oncology Research Unit, Pfizer Worldwide Research & Development, La Jolla Laboratories, San Diego, CA 92121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-13-355DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507642PMC
July 2012

Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2.

J Natl Cancer Inst 2011 Feb 23;103(4):334-46. Epub 2010 Dec 23.

Northern Institute for Cancer Research, University of Newcastle Upon Tyne, Medical School, Newcastle Upon Tyne, NE2 4HH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djq509DOI Listing
February 2011

P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer.

Mod Pathol 2011 Jan 17;24(1):64-81. Epub 2010 Sep 17.

Molecular Oncology Department, BC Cancer Research Centre, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.189DOI Listing
January 2011

PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity.

Clin Cancer Res 2010 Nov 9;16(21):5177-88. Epub 2010 Sep 9.

Translational Research Group in Oncology Research Unit, Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California 92121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-1343DOI Listing
November 2010

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.

Mol Cancer Ther 2007 Dec;6(12 Pt 1):3314-22

Department of Cancer Biology, Pfizer Global Research and Development, La Jolla Laboratories, 10724 Science Center Drive, La Jolla, CA 92121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-07-0365DOI Listing
December 2007

Gene expression profiling to characterize anticancer drug sensitivity.

Methods Mol Med 2005 ;111:197-231

Rebecca and John Moores UCSD Cancer Center, University of California-San Diego, La Jolla, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59259-889-7:197DOI Listing
June 2005

cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance.

Cancer Chemother Pharmacol 2005 Jan 16;55(1):1-11. Epub 2004 Sep 16.

Department of Medicine and the Cancer Center, University of California, 9500 Gilman Drive, La Jolla, San Diego, 92093-0058, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-004-0819-9DOI Listing
January 2005

Identification of transdominant-negative genetic suppressor elements derived from hMSH2 that mediate resistance to 6-thioguanine.

Mol Pharmacol 2002 Nov;62(5):1198-206

Cancer Center, University of California, San Diego, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/mol.62.5.1198DOI Listing
November 2002

Using mRNA expression profiling to determine anticancer drug efficacy.

Cytometry 2002 Jan;47(1):66-71

UCSD Cancer Center, University of California at San Diego, La Jolla, California 92037-0058, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.10037DOI Listing
January 2002